DB05455InvestigationalSmall molecule
SR 121463 is a nonpeptide aquaretic compound with potent selective antagonism of the vasopressin V2 (V1b) receptor subtype. It is a candidate for control of hyponatremia and in the treatment... It is a candidate for control of hyponatremia and in the treatment of syndrome of inappropriate secretion of anti-diuretic hormone (SIADH).
- Mechanism
- Curator reviewed
Selectively antagonizes v1b receptors.
- Primary indication
- Investigated for use/treatment in cardiovascular disorders, in the treatment of syndrome of inappropriate secretion of anti-diuretic hormone (SIADH) and in hyponatremia.Curator reviewed
- Code names
- SR 121463
Resolves to
Targets
What you can answer from here — as of April 23, 2025
Which drugs share a target with SR 121463, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account